Immucor, J&J Face Another Antitrust Class Action
Johnson & Johnson subsidiary Ortho-Clinical Diagnostics Inc. and rival Immucor Inc. have been hit with another proposed class action alleging they conspired to fix prices for blood reagents in the U.S....To view the full article, register now.
Already a subscriber? Click here to view full article